The introduction of biological treatment in pathologies such as psoriasis has meant a real revolution in terms of the therapeutic expectations of specialists. This article analyzes the impact of biosimilar drugs in this pathology. It has been published in Medical Gazette, and has had the collaboration of Biogen.